Literature DB >> 19375492

Protective effects of serum containing Ginkgo biloba extract on glomerulosclerosis in rat mesangial cells.

Daoquan Tang1, Zunjian Zhang, Yuanyuan Gao, Yaqin Wei, Lin Han.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Ginkgo biloba extract (GBE) is an ancient Chinese phytomedicine which was used to treat various ailments including circulatory and demential disorders. AIM OF THE STUDY: To study GBE's protective effects on the glomerulosclerosis of diabetic nephropathy (DN) in rat mesangial cells by serum pharmacological methods.
MATERIALS AND METHODS: The cultured mesangial cells were divided into seven groups: normal, solvent control, high glucose, low dose of GBE serum, moderate dose of GBE serum, high dose of GBE serum, and GBE. The activities of cell antioxidases, type IV collagen and laminin, Smad2/3 and Smad7, and TGF-beta(1) mRNA were measured by methods of spectrophotometry, radioimmunoassay, immunocytochemistry, and RT-PCR, respectively.
RESULTS: The intensity of oxidative stress decreased in the GBE serum-treated groups in comparison with the high glucose group. In addition, the expression of Smad2/3 was greatly reduced, whereas Smad7 expression increased; type IV collagen, laminin and TGF-beta(1) mRNA levels were also diminished.
CONCLUSION: These results suggest that GBE is protective agent against glomerulosclerosis in diabetic nephropathy of mesangial cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375492     DOI: 10.1016/j.jep.2009.04.017

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

Review 1.  Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials.

Authors:  Noori Al-Waili; Hamza Al-Waili; Thia Al-Waili; Khelod Salom
Journal:  Redox Rep       Date:  2017-03-09       Impact factor: 4.412

2.  Long-term outcome of 31 cases of refractory acute promyelocytic leukemia treated with compound realgar natural indigo tablets administered alternately with chemotherapy.

Authors:  Yanfeng Liu; Pengcheng He; Xiaoyan Cheng; Mei Zhang
Journal:  Oncol Lett       Date:  2015-06-02       Impact factor: 2.967

3.  Ginkgo biloba leaf extract prevents diabetic nephropathy through the suppression of tissue transglutaminase.

Authors:  Xiaoyan Yu; Qing Su; Jianan Geng; Hui Liu; Yumeng Liu; Jinming Liu; Yan Shi; Yinggang Zou
Journal:  Exp Ther Med       Date:  2021-02-08       Impact factor: 2.447

4.  Ginkgo biloba Extract for Patients with Early Diabetic Nephropathy: A Systematic Review.

Authors:  Lei Zhang; Wei Mao; Xinfeng Guo; Yifan Wu; Chuang Li; Zhaoyu Lu; Guobin Su; Xiaoyan Li; Zhuangzhu Liu; Rong Guo; Xina Jie; Zehuai Wen; Xusheng Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-24       Impact factor: 2.629

5.  Effects of Modified Simiao Decoction on IL-1 β and TNF α Secretion in Monocytic THP-1 Cells with Monosodium Urate Crystals-Induced Inflammation.

Authors:  Ya-Fei Liu; Sheng-Hao Tu; Zhe Chen; Yu Wang; Yong-Hong Hu; Hui Dong
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-05       Impact factor: 2.629

6.  Efficacy and safety of Ginkgo biloba for patients with early diabetic nephropathy: A protocol for systematic review and meta-analysis.

Authors:  Hongyun Wang; Meilin Yuan; Xinrong Zou
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.